PRESS RELEASE published on 01/17/2024 at 08:00, 2 years 2 months ago Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Published on 04/14/2026 at 13:15, 16 minutes ago Bayhorse Silver Announces Brokered LIFE Offering for Gross Proceeds of up to C$4.0 Million
Published on 04/14/2026 at 13:05, 26 minutes ago Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Published on 04/14/2026 at 13:00, 31 minutes ago Galway Launches District-Scale Geophysical Program to Accelerate Gold Discovery at Clarence Stream
Published on 04/14/2026 at 13:00, 31 minutes ago Gamma Resources Announces Amended Terms for Its U.S. Uranium Portfolio Lease Agreement
Published on 04/14/2026 at 13:00, 31 minutes ago Horizon Aircraft Reports Results for Third Quarter of Fiscal Year 2026 and Provides Business Update
Published on 04/14/2026 at 13:20, 10 minutes ago Annual Shareholder Meeting of Comet Holding AG approves all agenda items
Published on 04/14/2026 at 13:19, 11 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG initiates a cash capital increase while preserving subscription rights with an issue volume of up to approximately EUR 10.3 million.
Published on 04/14/2026 at 13:04, 26 minutes ago Aroundtown announces successful result of the voluntary Exchange Offer for GCP shares, increasing its holding in GCP to 81.5%
Published on 04/14/2026 at 13:02, 29 minutes ago Aroundtown announces successful result of the voluntary Exchange Offer for GCP shares, increasing its holding in GCP to 81.5%
Published on 04/14/2026 at 08:30, 5 hours 1 minute ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 18 hours 16 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 19 hours 16 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 19 hours 16 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 19 hours 21 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.